Malignant Melanoma in Oculocutaneous Albinism
- 1 November 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 125 (11) , 1583-1586
- https://doi.org/10.1001/archderm.1989.01670230125028
Abstract
To the Editor.— The recent spate of articles on photography of dysplastic nevi certainly creates medicolegal problems. The standard of care must vary with the availability of elaborate equipment, facilities, and the cost. Although some patients have numerous suspicious lesions, most do not. It is about this latter group that I write. The Polaroid camera shots provide an accurate, immediate photograph of a suspicious lesion at a cost of about $2 (1989). Even such shots of ten lesions at $20 is far below the cost of $100 mentioned by Slue and Knopf1,2 (now $125). Also, consider that follow-up may be needed at 6- to 12-month periods. I am further intrigued by identification of the location of the photographic lesion. There are alternative ways to do this without photography! A recent article mentioned the use of tattooing to permanently mark the location of an important lesion, especially those needing surgicalThis publication has 7 references indexed in Scilit:
- Sporadic dysplastic nevus syndrome in a tyrosinase-positive oculocutaneous albinoJournal of the American Academy of Dermatology, 1988
- Albinism with haemorrhagic diathesis: Hermansky-Pudlak syndrome.British Journal of Ophthalmology, 1985
- The Tanzanian human albino skin. Natural historyCancer, 1985
- Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinismJournal of the American Academy of Dermatology, 1984
- Malignant melanoma with oculocutaneous albinismJournal of the American Academy of Dermatology, 1982
- Albinism and amelanotic melanoma: occurrence in a child with positive test results for tyrosinaseArchives of Dermatology, 1982
- Melanoma in an AlbinoJAMA, 1963